Evidence mapPaperPMID 36351254Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2023

Loss of hepatic phosphoenolpyruvate carboxykinase 1 dysregulates metabolic responses to acute exercise but enhances adaptations to exercise training in mice.

Ferrol I Rome, Gregory L Shobert, William C Voigt, David B Stagg, Patrycja Puchalska, Shawn C Burgess, Peter A Crawford, Curtis C Hughey

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ferrol I RomeDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Gregory L ShobertDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
William C VoigtDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
David B StaggDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Patrycja PuchalskaDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Shawn C BurgessCenter for Human Nutrition, The University of Texas Southwestern Medical Center, Dallas, Texas.
Peter A CrawfordDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Curtis C HugheyDivision of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0003-2674-7359
University of Minnesota · USHumanN (United States) · US

Funding

Transplant Biology and TherapyP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · 1998 to 2025
$35.0M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · VANDERBILT UNIVERSITY · 2001 to 2005
$5.3M
Vanderbilt Diabetes Research CenterP30DK020593 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$1.8M
UT Southwestern NORCP30DK127984 · UT SOUTHWESTERN MEDICAL CENTER · 2025 to 2025
$1.2M
Factors Controlling Metabolic Flux in the Liver R01DK078184 · UT SOUTHWESTERN MEDICAL CENTER · 2025 to 2025
$509k
Regulation of lipogenesis by TCA cycle metabolismR01DK128168 · UT SOUTHWESTERN MEDICAL CENTER · 2025 to 2025
$416k
NCI NIH HHS P30 CA077598NIA NIH HHS R01 AG069781NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK127984NIDDK NIH HHS R01 DK078184NIDDK NIH HHS R01 DK091538NIDDK NIH HHS R01 DK128168NIDDK NIH HHS R56 DK078184NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Acute exercise increases liver gluconeogenesis to supply glucose to working muscles. Concurrently, elevated liver lipid breakdown fuels the high energetic cost of gluconeogenesis. This functional coupling between liver gluconeogenesis and lipid oxidation has been proposed to underlie the ability of regular exercise to enhance liver mitochondrial oxidative metabolism and decrease liver steatosis in individuals with nonalcoholic fatty liver disease. Herein we tested whether repeated bouts of increased hepatic gluconeogenesis are necessary for exercise training to lower liver lipids. Experiments used diet-induced obese mice lacking hepatic phosphoenolpyruvate carboxykinase 1 (KO) to inhibit gluconeogenesis and wild-type (WT) littermates.

Indexed as

GlucoseLiver3-Hydroxybutyric AcidAnimalsGluconeogenesisMicePhosphoenolpyruvate3-Hydroxybutyric AcidGlucosePhosphoenolpyruvategluconeogenesisglycogenolysisketone bodiesmitochondriaskeletal muscle

Identifiers

PMID36351254
PMCPMC9799143
OpenAlexW4308683402

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.